Revenue from the global urinary catheter market size is set to reach US$ 1.89 billion in 2024 and further rise at 3.6% CAGR to climb to US$ 2.68 billion by the end of 2034.
Urinary catheters are flexible tubes that are inserted into the bladder through the urethra to drain urine when a patient is unable to do so naturally. The market for urinary catheters has experienced steady growth, driven by factors such as the increasing prevalence of urinary incontinence, rising rates of surgeries requiring catheterization, and the growing aging population worldwide.
Urinary incontinence, a condition characterized by the involuntary loss of bladder control, is one of the leading drivers of the urinary catheter market. The prevalence of this condition increases with age, making the aging global population a significant factor in the market’s growth. According to the World Health Organization, the proportion of the global population aged 60 and above is expected to nearly double by 2050, reaching 2.1 billion. This demographic trend is likely to result in a higher incidence of urological disorders, including urinary incontinence, thereby boosting the demand for urinary catheters.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8242
The increasing number of surgical procedures, particularly in areas such as urology, gynecology, and oncology, also contributes to the growth of the urinary catheter market. Many surgeries require temporary catheterization to manage urine drainage during and after the procedure, ensuring patient comfort and preventing complications such as urinary retention. Additionally, the rising prevalence of chronic conditions such as diabetes, spinal cord injuries, and multiple sclerosis, which often lead to bladder dysfunction, further drives the demand for urinary catheters.
The urinary catheter market is segmented based on product type, material, application, end-user, and geography. By product type, the market is divided into indwelling (Foley) catheters, intermittent catheters, and external catheters. Indwelling catheters, which are designed for long-term use and are inserted into the bladder through the urethra or a small incision in the abdomen, hold the largest share of the market.
These catheters are widely used in hospitals and long-term care facilities for patients with chronic urinary retention or severe incontinence. Intermittent catheters, which are inserted temporarily and removed after bladder drainage, are also gaining popularity due to their lower risk of infection compared to indwelling catheters. External catheters, which are typically used by male patients and are applied outside the body, are preferred for short-term use and are associated with a lower risk of urinary tract infections (UTIs).
The market is also categorized based on the material used in catheter manufacturing, with silicone, latex, and others being the primary categories. Silicone catheters are favored for long-term use due to their biocompatibility, flexibility, and lower risk of allergic reactions. Latex catheters, while less expensive, may cause allergic reactions in some patients, limiting their use. However, latex catheters are still widely used, particularly in short-term applications, due to their lower cost and ease of use.
In terms of application, the urinary catheter market is segmented into urinary incontinence, surgery, benign prostatic hyperplasia (BPH), and others. Urinary incontinence remains the dominant application segment, driven by the high prevalence of the condition, particularly among the elderly and post-surgical patients. The use of catheters in surgery, especially in post-operative care, also represents a significant portion of the market, as catheterization is often necessary to manage urinary function during recovery. Benign prostatic hyperplasia, a common condition in older men that leads to urinary retention, is another important application area for urinary catheters.
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8242
Geographically, North America dominates the urinary catheter market, driven by the high prevalence of urological disorders, a well-established healthcare system, and the presence of leading medical device companies. The United States, in particular, is a major contributor to the market, with a large aging population and high rates of chronic conditions such as diabetes and obesity, which are risk factors for urinary incontinence and other bladder disorders. Europe follows closely, with countries such as Germany, France, and the United Kingdom leading the market due to their advanced healthcare infrastructure and growing elderly population.
The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, fueled by factors such as increasing healthcare expenditure, improving access to healthcare services, and a rapidly aging population. Countries like China, Japan, and India are experiencing significant growth in the urinary catheter market, supported by government initiatives to enhance healthcare infrastructure and address the needs of their aging populations.
The market is highly competitive, with key players such as B. Braun Melsungen AG, Coloplast A/S, Becton, Dickinson and Company (BD), and Teleflex Incorporated dominating the landscape.
These companies are investing in research and development to introduce new products, enhance the safety and efficacy of existing products, and expand their market presence through strategic partnerships, acquisitions, and geographic expansion. The introduction of advanced materials, innovative catheter designs, and improved manufacturing processes are expected to further drive market growth and address the evolving needs of patients and healthcare providers.